Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
379,380 A phase I clinical trial in which pazopanib and vorinostat were combined to treat patients with p53-mutant tumors suggested that HDAC inhibitors can abolish the proangiogenic function of mutant p53
This research compound is provided in lyophilized form and packaged in a 3ml vial to ensure stability and reliable handling
Comparison of chemical binding of structurally analogous compounds to GSH Guiding the study of detoxification pathways under the regulation of non-enzyme conjugation Non-enzymatic conjugation can assist the body in detoxification
Glutathione and vitamin C provide antioxidant defence against oxidative stress
A kinetic study of -glutamyltransferase (GGT)-mediated S-nitrosoglutathione catabolism
US$ 26.90
US$ 23.84
US$ 29.65
US$ 26.73
US$ 29.95
